Identifying drugs that may help extend human lifespan
Integrative Cross Species Analysis for Longevity Drug Target Identification
This study is looking for ways to help people age more slowly and stay healthier longer by finding new drug targets and understanding the biology of aging, which could lead to better treatments for age-related diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Translational Genomics Research Inst NIH-funded |
| Lab location | 1 site (Phoenix, United States) |
| Project ID | NIH-11144139 on NIH RePORTER |
What this research studies
This research investigates potential drug targets that could slow the aging process and delay age-related diseases. By analyzing data from both human studies and cross-species research, the project aims to discover biological markers and pathways that contribute to longevity. The approach includes examining metabolites and proteins in various tissues to understand healthy aging better. Patients may benefit from insights that could lead to new interventions aimed at promoting longer, healthier lives.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults interested in interventions that may promote healthy aging and longevity.
Not a fit: Patients who are not aging or do not have age-related health concerns may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of medications that enhance longevity and improve overall health in aging individuals.
How similar studies have performed: Previous research has shown promise in identifying longevity-enhancing compounds in non-human species, but this approach is still relatively novel in humans.
Where this research is happening
Phoenix, United States
- Translational Genomics Research Inst — Phoenix, United States (Active)
Researchers
- Principal investigator: Schork, Nicholas Joseph — Translational Genomics Research Inst
- Study coordinator: Schork, Nicholas Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.